Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants
| Name | Buprenorphine 2mg oral lyophilisates sugar free |
| BNF code | 0410030A0AAALAL |
| Virtual Therapeutic Moiety | Buprenorphine |
| Basis of preferred name | rINN - Recommended International Non-proprietary |
| Prescribing status | Valid as a prescribable product |
| Sugar free | ✓ |
| Gluten free | ✗ |
| Preservative free | ✗ |
| CFC free | ✗ |
| Dose form | Discrete |
| Unit dose form size | 1.000 |
| Unit dose form units | tablet |
| Unit dose unit of measure | tablet |
| Virtual Product Ingredient | |
|---|---|
| Ingredient | Buprenorphine hydrochloride |
| Basis of pharmaceutical strength | Based on Base Substance |
| Basis of strength substance identifier | 387173000 |
| Strength value numerator | 2.000 |
| Strength value numerator unit | mg |
| Ontology Drug Form & Route | |
| Form & Route | lyophilisate.oromucosal |
| Dose Form | |
| Formulation | Oral lyophilisate |
| Drug Route | |
| Route | Oromucosal |
| Controlled Drug Prescribing Information | |
| Controlled Drug category | Schedule 3 (CD No Register) |
| Actual Medicinal Products | |
| Espranor 2mg oral lyophilisates (Martindale Pharmaceuticals Ltd) | |
| Virtual Medicinal Product Packs | |
| Buprenorphine 2mg oral lyophilisates sugar free 28 tablet | |
| Buprenorphine 2mg oral lyophilisates sugar free 7 tablet | |
dm+d data retrieved from TRUD: release NHSBSA_11.2.0_20241118000001, imported on 19th November 2024 at 03:53:26.